stockrowInterparfums, Inc.
IPAR Consumer Defensive Household & Personal Products
Interparfums, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 2.49% from fiscal 2024.
- Revenue
- −0.02%
- EPS
- +3.90%
- Free cash flow
- −6.15%
- Total debt
- −28.5%
Quarter to September 2026, against a year earlier
Follow IPAR
Alert me
Interparfums, Inc. (IPAR) EBITDA
Interparfums, Inc.'s EBITDA for fiscal 2025 was $295.6M, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $292.6M. Over the past ten years it has ranged from $70.3M (fiscal 2015) to $303.2M (fiscal 2024); the current reading is higher than 91% of that period. Interparfums, Inc. ranks 11th of 28 Household & Personal Products companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $295.6M | (2.49%) |
| FY2024 | $303.2M | 12.82% |
| FY2023 | $268.7M | 23.92% |
| FY2022 | $216.8M | 34.90% |
| FY2021 | $160.7M | 103.09% |
| FY2020 | $79.2M | (30.24%) |
| FY2019 | $113.5M | 7.27% |
| FY2018 | $105.8M | 16.82% |
| FY2017 | $90.5M | 10.39% |
| FY2016 | $82.0M | 16.70% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $123.9M | 126.26% |
| Jun 2026 | $54.8M | (31.48%) |
| Mar 2026 | $79.9M | 135.28% |
| Dec 2025 | $34.0M | (70.48%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| CLX The Clorox Company compare | $1.3B |
| NWL Newell Brands Inc. compare | $833.0M |
| COTY Coty compare | $378.5M |
| SPB Spectrum Brands Holdings Inc. compare | $306.8M |
| IPAR Interparfums, Inc. | $292.6M |
| ELF e.l.f. Beauty compare | $221.4M |
| EPC Edgewell Personal Care Company compare | $100.0M |
| HELE Helen of Troy Limited compare | $78.3M |
| ODD ODDITY Tech Ltd. compare | $8.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on IPAR
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement